MetLife, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 6, 2026, covering the fiscal quarter ended September 30, 2026.

Key Highlights

  • Common shares outstanding: 628,442,143 shares of common stock were outstanding as of October 30, 2026, according to the filing.
  • Exchange and ticker: Common Stock (par value $0.01) is listed on the New York Stock Exchange under the symbol MET, as stated on the cover page.
  • Preferred stock series listed: Three additional securities trade on the New York Stock Exchange, including Floating Rate Non-Cumulative Preferred Stock Series A (MET PRA), Depositary Shares for 5.625% Non-Cumulative Preferred Stock Series E (MET PRE), and Depositary Shares for 4.75% Non-Cumulative Preferred Stock Series F (MET PRF).
  • Large accelerated filer: The registrant is classified as a large accelerated filer, as indicated on the cover page.
  • Incorporation: MetLife, Inc. is described in the filing as a Delaware corporation incorporated in 1999.
  • Forward-looking statements: The filing states that forward-looking statements "are not statements of historical fact or guarantees of future performance" and are subject to risks and uncertainties the company identifies across more than 35 enumerated risk factors.

MetLife's Third-Quarter 2026 Filing: Structure and Key Details

MetLife, Inc. (NYSE:MET) submitted its Form 10-Q for the quarterly period ended September 30, 2026, covering both three-month and nine-month periods ending on that date, as well as comparative periods from 2025. The filing includes unaudited interim condensed consolidated financial statements, with balance sheet data presented at September 30, 2026, and December 31, 2025. MetLife, a large global insurance and financial services company, operates across multiple business segments, as outlined in Note 2 of the financial statements.

The filing's table of contents shows 19 notes to the financial statements addressing topics including future policy benefits, policyholder account balances, market risk benefits, separate accounts, deferred policy acquisition costs, and investments. The company also includes sections on derivatives, fair value measurements, subordinated debt securities, equity, income taxes, earnings per common share, and contingencies. Management's Discussion and Analysis spans from page 100 to page 152, according to the filing's table of contents, and covers the company's financial condition and results of operations.

The filing enumerates more than 35 risk factors in its forward-looking statements section, citing risks that include interest rate movements, effects of tariff increases on the global economy, credit rating changes, litigation, cybersecurity exposures, and catastrophe risk, among others. The company states that "actual results may vary materially from what is expressed in or indicated by the forward-looking statements," and identifies these as the company's own projections subject to its cautionary language.

What Was Disclosed

MetLife, Inc. filed a quarterly report covering the period ended September 30, 2026. The filing confirmed 628,442,143 common shares outstanding as of October 30, 2026, identified four NYSE-listed securities, and classified the company as a large accelerated filer incorporated in Delaware in 1999.